Bextra

Get a free case evaluation<<<<<<<

On April 7, 2005, the Food and Drug Administration announced that it had asked Pfizer, Inc. to withdraw Bextra (valdecoxib) from the market, and that Pfizer had agreed to suspend sales and marketing of Bextra in the U.S. pending further discussions with the agency. The FDA based its decision, in part, on the increased risk of cardiovascular events such as heart attacks and strokes alongside reports of serious and potentially life-threatening skin reactions such as Stevens Johnsons Syndrome and toxic epidermal necrolysis.

More recent research has revealed that Bextra can more than double a patient's chance of a severe coronary event such as a heart attack, stroke or even death in some instances. This represents a potential risk factor even greater than the painkiller Vioxx, which was removed from the market in September 2004.

Pfizer has also recently warned doctors that Bextra can cause rare but serious skin reactions like Stevens Johnson Syndrome more often than any other drug in its class. These potentially deadly skin reactions occur most often in the first two weeks of Bextra treatment. Bextra now carries a warning about these skin reaction risks, which is the final warning step before a recall.

If you or a loved one has suffered a heart attack, stroke or from Stevens Johnson Syndrome while taking Bextra, you need a law firm that is experienced in handling these cases. If our firm is not qualified to handle your particular case we will be happy to use our experience and know-how to help you find a lawyer that can provide you with the legal representation and dedication you deserve. Remember, we never charge you any fees or expenses, unless your case is successful.

You can call us at 1-800-992-6878 or CLICK HERE to inquire by email.